Literature DB >> 25408411

Gene editing using ssODNs with engineered endonucleases.

Fuqiang Chen1, Shondra M Pruett-Miller, Gregory D Davis.   

Abstract

Gene editing using engineered endonucleases, such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nucleases, requires the creation of a targeted, chromosomal DNA double-stranded break (DSB). In mammalian cells, these DSBs are typically repaired by one of the two major DNA repair pathways: nonhomologous end joining (NHEJ) or homology-directed repair (HDR). NHEJ is an error-prone repair process that can result in a wide range of end-joining events that leads to somewhat random mutations at the site of DSB. HDR is a precise repair pathway that can utilize either an endogenous or exogenous piece of homologous DNA as a template or "donor" for repair. Traditional gene editing via HDR has relied on the co-delivery of a targeted, engineered endonuclease and a circular plasmid donor construct. More recently, it has been shown that single-stranded oligodeoxynucleotides (ssODNs) can also serve as DNA donors and thus obviate the more laborious and time-consuming plasmid vector construction process. Here we describe the use of ssODNs for making defined genome modifications in combination with engineered endonucleases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25408411     DOI: 10.1007/978-1-4939-1862-1_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates.

Authors:  Zulema Romero; Anastasia Lomova; Suzanne Said; Alexandra Miggelbrink; Caroline Y Kuo; Beatriz Campo-Fernandez; Megan D Hoban; Katelyn E Masiuk; Danielle N Clark; Joseph Long; Julie M Sanchez; Miriam Velez; Eric Miyahira; Ruixue Zhang; Devin Brown; Xiaoyan Wang; Yerbol Z Kurmangaliyev; Roger P Hollis; Donald B Kohn
Journal:  Mol Ther       Date:  2019-05-24       Impact factor: 11.454

2.  CRISPR-Cas9-Mediated Correction of the 1.02 kb Common Deletion in CLN3 in Induced Pluripotent Stem Cells from Patients with Batten Disease.

Authors:  Erin R Burnight; Laura R Bohrer; Joseph C Giacalone; Darcey L Klaahsen; Heather T Daggett; Jade S East; Robert A Madumba; Kristan S Worthington; Robert F Mullins; Edwin M Stone; Budd A Tucker; Luke A Wiley
Journal:  CRISPR J       Date:  2018-02

Review 3.  The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair.

Authors:  Maria Jasin; James E Haber
Journal:  DNA Repair (Amst)       Date:  2016-05-12

Review 4.  Editing the genome of hiPSC with CRISPR/Cas9: disease models.

Authors:  Andrew R Bassett
Journal:  Mamm Genome       Date:  2017-03-16       Impact factor: 2.957

5.  Mechanisms of precise genome editing using oligonucleotide donors.

Authors:  Yinan Kan; Brian Ruis; Taylor Takasugi; Eric A Hendrickson
Journal:  Genome Res       Date:  2017-03-29       Impact factor: 9.043

Review 6.  Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering.

Authors:  Francesco Piras; Anna Kajaste-Rudnitski
Journal:  Gene Ther       Date:  2020-07-13       Impact factor: 5.250

Review 7.  The amphipod crustacean Parhyale hawaiensis: An emerging comparative model of arthropod development, evolution, and regeneration.

Authors:  Dennis A Sun; Nipam H Patel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-06-11       Impact factor: 5.814

8.  Cas9 Mediated Correction of β-catenin Mutation and Restoring the Expression of Protein Phosphorylation in Colon Cancer HCT-116 Cells Decrease Cell Proliferation in vitro and Hamper Tumor Growth in Mice in vivo.

Authors:  Yanlan Li; Xiangning Li; Jiayao Qu; Dixian Luo; Zheng Hu
Journal:  Onco Targets Ther       Date:  2020-01-06       Impact factor: 4.147

9.  Optimized two-step electroporation process to achieve efficient nonviral-mediated gene insertion into primary T cells.

Authors:  Ming Yang; Diane Tkach; Alex Boyne; Selena Kazancioglu; Aymeric Duclert; Laurent Poirot; Philippe Duchateau; Alexandre Juillerat
Journal:  FEBS Open Bio       Date:  2021-10-01       Impact factor: 2.693

10.  Programmed genome editing of the omega-1 ribonuclease of the blood fluke, Schistosoma mansoni.

Authors:  Wannaporn Ittiprasert; Victoria H Mann; Shannon E Karinshak; Avril Coghlan; Gabriel Rinaldi; Geetha Sankaranarayanan; Apisit Chaidee; Toshihiko Tanno; Chutima Kumkhaek; Pannathee Prangtaworn; Margaret M Mentink-Kane; Christina J Cochran; Patrick Driguez; Nancy Holroyd; Alan Tracey; Rutchanee Rodpai; Bart Everts; Cornelis H Hokke; Karl F Hoffmann; Matthew Berriman; Paul J Brindley
Journal:  Elife       Date:  2019-01-15       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.